Cure My Disease

Don't miss your cure!

 Log in / Sign up

One extra injection could make labor pain relief easier and faster

NCT ID NCT07327918

Symptom relief Sponsor: Al-Azhar University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting a small amount of local anesthetic through the epidural needle before inserting the catheter makes placement easier and more successful. Researchers will compare this method to the standard approach in 216 women requesting painless labor. The goal is to see if the injection increases first-attempt success and reduces procedure time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
local anesthetic (lidocaine or similar)
What this could lead to
If it works, this could make epidural placement faster and more reliable for women in labor, reducing discomfort and delays.
What could go wrong
This is a single-center trial with 216 participants, so results may not apply to all hospitals. The injection itself carries small risks like allergic reaction or temporary numbness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 216 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18-40 years. * ASA physical status II or III. * Singleton pregnancy. * Gestational age ≥37 weeks. * Active labour with cervical dilatation ≥3 cm. * Cephalic presentation. * Requesting epidural analgesia for painless labour. * Ability to provide written informed consent. Exclusion Criteria: * • Refusal to participate or to sign informed consent. * Age \<18 or \>40 years. * ASA status ≥IV. * Allergy to local anesthetics or saline. * Coagulopathy or platelet count \<100,000/mm³. * Local infection at the insertion site. * Severe spinal deformity (scoliosis, kyphosis). * Multiple pregnancy. * Non-cephalic presentation (breech, transverse). * Antepartum hemorrhage or placenta previa. * Severe preeclampsia or eclampsia. * Signs of fetal distress. * Previous lumbar spine surgery. * Difficult epidural anatomy (on ultrasound or palpation). * BMI \>40 kg/m²

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Labour analgesia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Labour analgesia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Al-Azhar University

    Cairo, Egypt, 11865, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.